AAAAAA

   
Results: 1-10 |
Results: 10
Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv
Authors: Xu, L Tang, WH Huang, CC Alexander, W Xiang, LM Pirollo, KF Rait, A Chang, EH
Citation: L. Xu et al., Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv, MOL MED, 7(10), 2001, pp. 723-734
Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer
Authors: Rait, AS Pirollo, KF Rait, V Krygier, JE Xiang, LM Chang, EH
Citation: As. Rait et al., Inhibitory effects of the combination of HER-2 antisense oligonucleotide and chemotherapeutic agents used for the treatment of human breast cancer, CANC GENE T, 8(10), 2001, pp. 728-739
Downmodulation of bFGF-binding protein expression following restoration ofp53 function
Authors: Sherif, ZA Nakai, S Pirollo, KF Rait, A Chang, EH
Citation: Za. Sherif et al., Downmodulation of bFGF-binding protein expression following restoration ofp53 function, CANC GENE T, 8(10), 2001, pp. 771-782
Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy
Authors: Xu, L Pirollo, KF Chang, EH
Citation: L. Xu et al., Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy, J CONTR REL, 74(1-3), 2001, pp. 115-128
Tp53 gene therapy: a key to modulating resistance to anticancer therapies?
Authors: Chang, EH Pirollo, KF Bouker, KB
Citation: Eh. Chang et al., Tp53 gene therapy: a key to modulating resistance to anticancer therapies?, MOL MED TOD, 6(9), 2000, pp. 358-364
Does p53 status influence tumor response to anticancer therapies?
Authors: Pirollo, KF Bouker, KB Chang, EH
Citation: Kf. Pirollo et al., Does p53 status influence tumor response to anticancer therapies?, ANTI-CANC D, 11(6), 2000, pp. 419-432
Targeted p53 gene therapy-mediated radiosensitization and chemosensitization
Authors: Chang, EH Xu, L Pirollo, KF
Citation: Eh. Chang et al., Targeted p53 gene therapy-mediated radiosensitization and chemosensitization, CANC DRUG, 5, 2000, pp. 519-536
Systemic p53 gene therapy in combination with radiation results in human tumor regression
Authors: Xu, L Pirollo, KF Rait, A Murray, AL Chang, EH
Citation: L. Xu et al., Systemic p53 gene therapy in combination with radiation results in human tumor regression, TUMOR TARG, 4(2), 1999, pp. 92-104
Sensitization of breast cancer cells to taxol by antisense HER-2 oligonucleotides
Authors: Rait, A Krygier, JE Pirollo, KF Chang, EH
Citation: A. Rait et al., Sensitization of breast cancer cells to taxol by antisense HER-2 oligonucleotides, ANTISENSE N, 9(4), 1999, pp. 403-408
Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts
Authors: Xu, LA Pirollo, KF Tang, WH Rait, A Chang, EH
Citation: La. Xu et al., Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts, HUM GENE TH, 10(18), 1999, pp. 2941-2952
Risultati: 1-10 |